{
    "clinical_study": {
        "@rank": "125893", 
        "arm_group": [
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator"
            }, 
            {
                "arm_group_label": "Parathyroid hormone", 
                "arm_group_type": "Experimental"
            }
        ], 
        "brief_summary": {
            "textblock": "Hypothesis:\n\n      The investigators want to study whether parathyroid hormone improves healing of humerus\n      after a fracture. The investigators will assess healing of the humerus with Constant score."
        }, 
        "brief_title": "Parathyroid Hormone for the Treatment of Humerus Fractures", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Shoulder Fractures", 
        "condition_browse": {
            "mesh_term": [
                "Fractures, Bone", 
                "Shoulder Fractures"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  proximal humeral fracture eligible for conservative treatment.\n\n          -  able to understand the protocol\n\n          -  signs an informed consent\n\n        Exclusion Criteria:\n\n          -  liver disease\n\n          -  kidney disease\n\n          -  severe osteoporosis\n\n          -  malignant disease\n\n          -  bone metabolic disease\n\n          -  oral treatment with bisphosphonates during the last 3 months.\n\n          -  treatment with Denosumab during the last 6 months.\n\n          -  intravenous treatment with bisphosphonates during the last 12 months."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "65 Years"
        }, 
        "enrollment": {
            "#text": "72", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 12, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01687374", 
            "org_study_id": "HvH-2011-545-1"
        }, 
        "intervention": [
            {
                "arm_group_label": "Parathyroid hormone", 
                "description": "100 micrograms of 1-84 parathyroid hormone daily for 8 weeks, subcutaneous injection.", 
                "intervention_name": "1-84 parathyroid hormone", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Saline injection daily for 8 weeks.", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Hormones"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "proximal humeral fracture", 
        "lastchanged_date": "September 13, 2012", 
        "location": {
            "contact": {
                "email": "hyld@dadlnet.dk", 
                "last_name": "Lars Hyld, DMSc"
            }, 
            "contact_backup": {
                "email": "ulrichbangbang@gmail.com", 
                "last_name": "Ulrich C Bang, M.D."
            }, 
            "facility": {
                "address": {
                    "city": "Hvidovre", 
                    "country": "Denmark", 
                    "zip": "2650"
                }, 
                "name": "Hvidovre Hospital"
            }, 
            "investigator": [
                {
                    "last_name": "Ulrich C Bang, M.D.", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Aage Vestergaard, M.D.", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "2", 
        "official_title": "Phase IV Study of the Effect of Parathyroid Hormone on Fractures of the Humerus", 
        "overall_contact": {
            "email": "hyld@dadlnet.dk", 
            "last_name": "Lars Hyldstrup, MDSc"
        }, 
        "overall_contact_backup": {
            "email": "ulrichbangbang@gmail.com", 
            "last_name": "Ulrich C Bang, M.D."
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Denmark: National Board of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2012", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Constant score summarizes the function of the arm using a questionnaire (activities of daily living - ADL) and functional testing of the arm.", 
            "measure": "Changes in constant score", 
            "safety_issue": "No", 
            "time_frame": "5, 8, 11, 23, and 104 weeks."
        }, 
        "reference": [
            {
                "PMID": "19594305", 
                "citation": "Aspenberg P, Genant HK, Johansson T, Nino AJ, See K, Krohn K, Garc\u00eda-Hern\u00e1ndez PA, Recknor CP, Einhorn TA, Dalsky GP, Mitlak BH, Fierlinger A, Lakshmanan MC. Teriparatide for Acceleration of Fracture Repair in Humans: A Prospective, Randomized, Double-blind Study of 102 Postmenopausal Women with Distal Radial Fractures. J Bone Miner Res. 2009 Jul 13; [Epub ahead of print]"
            }, 
            {
                "PMID": "21915572", 
                "citation": "Peichl P, Holzer LA, Maier R, Holzer G. Parathyroid hormone 1-84 accelerates fracture-healing in pubic bones of elderly osteoporotic women. J Bone Joint Surg Am. 2011 Sep 7;93(17):1583-7. doi: 10.2106/JBJS.J.01379."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01687374"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Hvidovre University Hospital", 
            "investigator_full_name": "Ulrich Bang", 
            "investigator_title": "Principal investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Oxford shoulder score is a questionnaire that assesses the function of the arm through the evaluation of the participant.", 
                "measure": "Changes in Oxford Shoulder Score", 
                "safety_issue": "No", 
                "time_frame": "5, 8, 11, 23, and 104 weeks."
            }, 
            {
                "measure": "Changes in bone formation evaluated by X-ray.", 
                "safety_issue": "No", 
                "time_frame": "5, 8, 11, 23, and 104 weeks."
            }, 
            {
                "description": "sodium, potassium, creatinine, liver enzymes, vitamin D, parathyroid hormone, alkaline phosphatase, hemoglobin, magnesium, calcium, zinc.", 
                "measure": "Changes in biochemical bone markers", 
                "safety_issue": "Yes", 
                "time_frame": "0, 5, 25 weeks"
            }, 
            {
                "description": "Regulatory CD3+CD4+CD25+Foxp3+ T lymphocytes.", 
                "measure": "Changes in regulatory T lymphocytes", 
                "safety_issue": "No", 
                "time_frame": "0, 8, 24 weeks"
            }
        ], 
        "source": "Hvidovre University Hospital", 
        "sponsors": {
            "collaborator": {
                "agency": "Takeda", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Hvidovre University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2012"
    }
}